These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2536599

  • 21. Atrial natriuretic factor (ANF 103-126) enhances volume- and pressor-induced heart rate response in the conscious rat.
    Marks ES, Ohman KP, Keiser HR.
    Acta Physiol Scand; 1990 Feb; 138(2):161-5. PubMed ID: 2138404
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The dihydropyridine calcium channel blocker BAY t 7207 attenuates the exercise induced increase in plasma ANF and cyclic GMP in patients with mildly impaired left ventricular function.
    Kentsch M, Otter W, Drummer C, Peinke V, Theisen K, Müller-Esch G, Gerzer R.
    Eur J Clin Pharmacol; 1995 Feb; 49(3):177-82. PubMed ID: 8665993
    [Abstract] [Full Text] [Related]

  • 25. Atrial natriuretic factor potentiates the human forearm vasoconstrictor response to sympathetic stimulation.
    Jansen TL, Smits P, Lenders JW, Jacobs MC, Willemsen J, Thien T.
    Clin Sci (Lond); 1994 Mar; 86(3):275-83. PubMed ID: 8156738
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Atriopeptins and nitroprusside provoke opposite changes in cGMP and cAMP levels in human macrophages.
    Houdijk AP, Adolfs MJ, Bonta IL, De Jonge HR.
    Eur J Pharmacol; 1990 Apr 25; 179(3):413-7. PubMed ID: 1694768
    [Abstract] [Full Text] [Related]

  • 28. Differential hemodynamic and sympathoadrenal effects of sodium nitroprusside and hydralazine in hypertensive subjects.
    Shepherd AM, Irvine NA.
    J Cardiovasc Pharmacol; 1986 Apr 25; 8(3):527-33. PubMed ID: 2425168
    [Abstract] [Full Text] [Related]

  • 29. Chronic vs. acute hemodynamic effects of atrial natriuretic factor in conscious rats.
    Harrison-Bernard LM, Vari RC, Holleman WH, Trippodo NC, Barbee RW.
    Am J Physiol; 1991 Jan 25; 260(1 Pt 2):R247-54. PubMed ID: 1825157
    [Abstract] [Full Text] [Related]

  • 30. Effects of clonidine and dihydralazine on plasma ANF and cyclic GMP levels in humans during volume loading.
    Müller T, Heim JM, Weil J, Wehling M, Witzgall H, Gerzer R.
    J Cardiovasc Pharmacol; 1987 Jan 25; 10 Suppl 12():S163-6. PubMed ID: 2455172
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Influence of atrial natriuretic factor on 5-(N-ethyl-N-isopropyl)amiloride-sensitive 22Na+ uptake in rabbit aorta.
    Gupta S, Cragoe EJ, Deth RC.
    J Pharmacol Exp Ther; 1989 Mar 25; 248(3):991-6. PubMed ID: 2539468
    [Abstract] [Full Text] [Related]

  • 33. Inhibitory effect of atrial natriuretic factor on sympathetic ganglionic neurotransmission in humans.
    Floras JS.
    Am J Physiol; 1995 Aug 25; 269(2 Pt 2):R406-12. PubMed ID: 7653663
    [Abstract] [Full Text] [Related]

  • 34. Hemodynamic responses to atrial natriuretic factor in nephrectomized rabbits: attenuation of the circulatory consequences of acute volume expansion.
    Volpe M, Vecchione F, Cuocolo A, Lembo G, Pignalosa S, Condorelli M, Trimarco B.
    Circ Res; 1988 Aug 25; 63(2):322-9. PubMed ID: 2969306
    [Abstract] [Full Text] [Related]

  • 35. Vasodilator properties of atrial natriuretic factor: a comparison with nitroglycerin, nitroprusside, and phentolamine during cardiopulmonary bypass.
    Hynynen M, Palojoki R, Salmenperä M, Tikkanen I, Harjula A, Fyhrquist F, Heinonen J.
    J Cardiothorac Anesth; 1989 Dec 25; 3(6):720-5. PubMed ID: 2535309
    [Abstract] [Full Text] [Related]

  • 36. Effects of atrial natriuretic factor on blood flow distribution and vascular resistance in conscious dogs.
    Shen YT, Graham RM, Vatner SF.
    Am J Physiol; 1991 Jun 25; 260(6 Pt 2):H1893-902. PubMed ID: 1829333
    [Abstract] [Full Text] [Related]

  • 37. Cardiovascular, renal and endocrine responses to low doses of atrial natriuretic factor in mild essential hypertension.
    Cusson JR, Thibault G, Kuchel O, Hamet P, Cantin M, Larochelle P.
    J Hum Hypertens; 1989 Apr 25; 3(2):89-96. PubMed ID: 2547952
    [Abstract] [Full Text] [Related]

  • 38. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW, Canepa-Anson R, Armstrong PW.
    J Cardiovasc Pharmacol; 1992 May 25; 19(5):691-700. PubMed ID: 1381766
    [Abstract] [Full Text] [Related]

  • 39. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P.
    Am J Gastroenterol; 1997 May 25; 92(5):852-7. PubMed ID: 9149200
    [Abstract] [Full Text] [Related]

  • 40. The inotropic effect of atrial natriuretic factor in the anesthetized rabbit.
    Rankin AJ, Swift FV.
    Pflugers Arch; 1990 Dec 25; 417(4):353-9. PubMed ID: 2150434
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.